CHEBI:77735 - ossamycin

ChEBI IDCHEBI:77735
ChEBI Nameossamycin
Stars
DefinitionA macrolide antibiotic that was originally isolated from the culture broths of Streptomyces hygroscopicus var. ossamyceticus.
Last Modified18 March 2014
SubmitterSteve
DownloadsMolfile
FormulaC49H85NO14
Net Charge0
Average Mass912.212
Monoisotopic Mass911.59701
SMILES[H][C@]12/C=C/CCCCC[C@@](C)(O)[C@H](O)[C@@H](O[C@H]3CC[C@H](N(C)C)[C@H](C)O3)[C@H](O)[C@@H](C)[C@H](O)[C@](C)(O)/C=C/C(=O)O[C@H]3C[C@@]4(CCC[C@H](C[C@H](O)CC)O4)O[C@@H](C[C@]1(O)OC(C)(C)C2)[C@H]3C
InChIInChI=1S/C49H85NO14/c1-11-34(51)26-35-19-17-24-48(62-35)28-37-30(2)38(63-48)29-49(58)33(27-45(5,6)64-49)18-15-13-12-14-16-23-46(7,56)44(55)42(61-40-21-20-36(50(9)10)32(4)59-40)41(53)31(3)43(54)47(8,57)25-22-39(52)60-37/h15,18,22,25,30-38,40-44,51,53-58H,11-14,16-17,19-21,23-24,26-29H2,1-10H3/b18-15+,25-22+/t30-,31+,32-,33+,34+,35+,36-,37-,38-,40-,41+,42-,43-,44+,46+,47+,48+,49-/m0/s1
InChIKeyXGECDDPXIKFBTE-AUFVQPSPSA-N
Roles Classification
Biological Roles:
bacterial metabolite  Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
antimicrobial agent  A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
Application:
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
ChEBI Ontology
Outgoing Relation(s)
ossamycin (CHEBI:77735) has role antineoplastic agent (CHEBI:35610)
ossamycin (CHEBI:77735) has role bacterial metabolite (CHEBI:76969)
ossamycin (CHEBI:77735) is a cyclic hemiketal (CHEBI:59780)
ossamycin (CHEBI:77735) is a macrolide antibiotic (CHEBI:25105)
ossamycin (CHEBI:77735) is a organic heterotetracyclic compound (CHEBI:38163)
ossamycin (CHEBI:77735) is a secondary alcohol (CHEBI:35681)
ossamycin (CHEBI:77735) is a spiroketal (CHEBI:72600)
ossamycin (CHEBI:77735) is a tertiary alcohol (CHEBI:26878)
IUPAC Name 
(3aS,4E,6'R,11R,12R,13S,14R,15R,16S,17R,18E,22S,24R,26S,27aS,28R)-13-{[(2S,5S,6S)-5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-11,12,14,16,17,27a-hexahydroxy-6'-[(2R)-2-hydroxybutyl]-2,2,11,15,17,28-hexamethyl-2,3,3',3a,4',5',6,6',7,8,9,10,11,12,13,14,15,16,17,22,23,26,27,27a-tetracosahydro-20H-spiro[22,26-methanofuro[2,3-h][1,5]dioxacyclohexacosine-24,2'-pyran]-20-one
Manual XrefsDatabases
US3271253Patent
Registry NumbersSources
Reaxys:7510041Reaxys
CAS:11015-84-2ChemIDplus
Citations